You're contacting media contact of this press release

Title: Healthful Plus Highlights CoreAge Rx NAD+ Injectable as a Leading NAD+ Therapy Option for Longevity and Cellular Wellness

Wichita Falls, TX, United States, 30th Apr 2026 - Health and wellness publication Healthful Plus has published a new review article examining the growing interest in NAD+ wellness therapies, with the publication recognizing CoreAge Rx’s NAD+ Injectable as a leading product in the NAD+ injectable therapy category.The article, published on Healthful Plus, explores how CoreAge Rx’s physician-guided telehealth platform is expanding access to longevity-focused wellness therapies through its NAD+ Injectable treatment. The review discusses the therapy’s delivery method, potential wellness applications, physician oversight model, and growing interest in mitochondrial support and healthy aging solutions.According to the published review, CoreAge Rx’s NAD+ Injectable is designed as part of a broader “Brain + Body Energy Protocol” focused on supporting cellular energy production, cognitive performance, and metabolic wellness through direct systemic delivery of Nicotinamide Adenine Dinucleotide (NAD+).NAD+ Injectable is administered through intramuscular or subcutaneous injection and is intended to provide rapid absorption and high bioavailability. CoreAge Rx states that NAD+ plays a critical role in mitochondrial function, DNA repair, metabolic regulation, and healthy cellular aging. The company also notes that natural NAD+ levels decline with age, which may contribute to fatigue, cognitive decline, inflammation, and reduced metabolic efficiency.The Healthful Plus review highlights several areas associated with the therapy, including support for:Cellular energy productionMitochondrial efficiencyCognitive performance and mental clarityPhysical stamina and enduranceDNA repair and cellular resilienceHealthy aging and long-term wellness supportThe article further notes that CoreAge Rx...

This press release is issued by King Newswire